Dr. Jeffrey Owen Clayman, MD

Dr. Clayman practices at Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health.

Dr. Clayman's NPI, 1477509206, was assigned on May 25, 2006. Dr. Clayman graduated from UMass Chan Medical School in 1999. Dr. Clayman holds Massachusetts license 211111.

Dr. Clayman's primary practice is Lahey Clinic, at 41 & 45 Mall Road, Burlington, MA 01803 in Middlesex County. The practice phone is (781) 744-5100.

Dr. Clayman's primary practice is Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health. Dr. Clayman is also affiliated with Beth Israel Deaconess Medical Center. The medical group on file is Lahey Clinic. Dmand AI also links Dr. Clayman to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Clayman practices, 6 sites in all. Vendor and product names are available with a free account.

Nuclear cardiology is Dr. Clayman's primary specialty in the NPI Registry, under taxonomy code 207UN0901X. Dr. Clayman is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Clayman's licenses on file in 3 states: Massachusetts, Florida and New Hampshire.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic embolism thrombosis and chronic hypertension among the conditions Dr. Clayman treats.

CMS data shows 10,910 Medicare services from Dr. Clayman across 23 procedure codes in 2024, for 6,367 Medicare patients. Medicare paid $166,306 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 6,367 Medicare patients who saw Dr. Clayman in 2024. The largest group is 75 to 84, with 2,511 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Clayman's median patient age at 74, with 47% women.

In 2024, Dr. Clayman wrote 7,660 Medicare Part D claims for 979 patients. 81% of them were for generic drugs. CMS names the drug for 7,396 of them, across 62 drugs with 11 or more claims each, at $1,369,972 in total drug cost. In 2023, CMS named 6,543 claims across 61 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Clayman for performance year 2024, reported through an alternative payment model (APM). Dr. Clayman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Clayman as offering telehealth.

CMS Open Payments shows 1 general payment to Dr. Clayman from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Lantheus Medical Imaging, Inc. paid the most, $20.

Dmand AI lists 1 award for Dr. Clayman.

Dr. Clayman graduated from UMass Chan Medical School in 1999. Dr. Clayman is a member of ACC.

Dr. Clayman is in network with 15 carriers, including United Healthcare, Aetna and Elevance. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.